Accession Number: | 0001209191-20-038510 |
Date: | 2020-06-19 |
Issuer: | VIR BIOTECHNOLOGY, INC. (VIR) |
Original Submission Date: |
VIRGIN HERBERT
C/O VIR BIOTECHNOLOGY, INC.
499 ILLINOIS STREET, SUITE 500
SAN FRANCISCO, CA 94158
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-06-19 | M | 3,510 | a | $1.53 | 3,510 | direct | ||
COMMON STOCK | 2020-06-19 | S | 1,755 | d | $38.00 | 1,755 | direct | ||
COMMON STOCK | 2020-06-19 | S | 1,755 | d | $38.00 | 0 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 1.53 | 2020-06-19 | deemed execution date | M | 3,510 (d) | 2028-01-26 | common stock 3,510 | $1.53 | 538,875 | direct |
ID | footnote |
---|---|
f1 | the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on april 14, 2020. |
f2 | 1/4 of the shares subject to the stock option vested and became exercisable on january 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. |